Skip to main content
. 2020 Sep 8;21(2):231–240. doi: 10.1007/s40256-020-00436-8

Fig. 2.

Fig. 2

Forest plots comparing major and CRNM bleeding and MACE between patients treated with potent oral P2Y12 inhibitors versus clopidogrel. CRNM clinically relevant non-major, MACE major adverse cardiovascular events, M-H Mantel–Haenszel, CI confidence interval, df degrees of freedom, inhib inhibitors